EC Number   |
IC50 Value |
IC50 Value Maximum |
Inhibitor |
Reference |
|---|
   3.4.24.B10 | 0.0000167 |
- |
N-[(2E)-3-(3-bromophenyl)-2-[(furan-2-ylcarbonyl)amino]prop-2-enoyl]glycine |
IC50: 16.7 nM |
667947 |
| 3.4.24.B10 | 0.0000248 |
- |
N-[(2E)-3-(4-bromofuran-2-yl)-2-[[(5-bromofuran-2-yl)carbonyl]amino]prop-2-enoyl]alanine |
IC50: 24.8 nM |
667947 |
| 3.4.24.B10 | 0.000025 |
- |
batimastat |
with 5-Fam-HALAQA(homophenylalanine)RSK-NH2 as substrate, at pH 8.0 and 22°C |
733079 |
| 3.4.24.B10 | 0.000028 |
- |
batimastat |
with 5-Fam-FFLAQA(homophenylalanine)RSK-NH2 as substrate, at pH 8.0 and 22°C |
733079 |
| 3.4.24.B10 | 0.0000405 |
- |
N-[(2E)-3-(2-fluorophenyl)-2-[(phenylcarbonyl)amino]prop-2-enoyl]valine |
IC50: 40.5 nM |
667947 |
| 3.4.24.B10 | 0.0000423 |
- |
N-[(2E)-3-furan-2-yl-2-[(furan-2-ylcarbonyl)amino]prop-2-enoyl]alanine |
IC50: 42.3 nM |
667947 |
| 3.4.24.B10 | 0.00012 |
- |
MMP inhibitor V |
with 5-Fam-FFLAQA(homophenylalanine)RSK-NH2 as substrate, at pH 8.0 and 22°C |
733079 |
| 3.4.24.B10 | 0.00018 |
- |
MMP inhibitor V |
with 5-Fam-HALAQA(homophenylalanine)RSK-NH2 as substrate, at pH 8.0 and 22°C |
733079 |
| 3.4.24.B10 | 0.00035 |
- |
TAPI-0 |
with 5-Fam-HALAQA(homophenylalanine)RSK-NH2 as substrate, at pH 8.0 and 22°C |
733079 |
| 3.4.24.B10 | 0.0004 |
- |
TAPI-0 |
with 5-Fam-FFLAQA(homophenylalanine)RSK-NH2 as substrate, at pH 8.0 and 22°C |
733079 |
